AVBP
ArriVent BioPharma, Inc.Healthcare$24.89
▲ Bullish
Mkt Cap: $1.10B|Float: 27.7M|SI: 26.1%|DTC: 13.2
Data as of market close Apr 2, 2026
IV Rank
56
IV Pctl
56%
HV 20d
65.7%
52W Range
$15-$27
ATR(14)
$1.38
Exp. Move
±16.3%
P/C Ratio
0.26
Earnings
May 15
GEX Positive
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
Low Put/Call
AVBP Key Options Data
- IV Rank
- 56.4%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $20.00
- Expected Move
- ±16.3%
- Put/Call OI
- 0.26
- Net Premium
- $0.1M
- Spot Price
- $24.89
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$4.05 | ±16.3% | $20.84 | $28.94 |
| 2026-05-15 | 43 | ±$2.25 | ±9.0% | $22.64 | $27.14 |
| 2026-07-17 | 106 | ±$14.10 | ±56.6% | $10.79 | $38.99 |
Explore AVBP options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.